Johnna Perdrizet

21PUBLICATIONS
23CO-AUTHORS
Economic models and forecastingNeonatologyInfant and child healthAdolescent healthSocial determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 21, 2025
Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in Germany.

Johnna Perdrizet, Dominik Schröder, Felicitas Kühne

|Feb 06, 2025
Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme.

Esra Çakar, An Ta, Michel Peters

|Feb 03, 2025
Delayed Transition to 20-Valent Pneumococcal Conjugate Vaccine in Pediatric National Immunization Programs: Forgone Public Health and Economic Benefit.

Johnna Perdrizet, An Ta, Liping Huang

|Sep 16, 2024
An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population.

Ann-Charlotte Fridh, Andreas Palmborg, An Ta

|Jul 26, 2024
Pediatric Pneumococcal Conjugate Vaccine and Dosing Schedule Perceptions Among Health Care Providers and Caregivers in Germany, France, Spain, and Greece.

Johnna E Perdrizet, Mark H Rozenbaum, Matthew J Heffler

|May 11, 2024
Cost-effectiveness of PCV20 to Prevent Pneumococcal Disease in the Pediatric Population: A German Societal Perspective Analysis.

An Ta, Felicitas Kühne, Maren Laurenz

Pageof 4

Frequent Collaborators

7 joint publications

Emily K Horn

6 joint publications

Matthew Wasserman

3 joint publications

Jennifer Nailes

2 joint publications

Canna J Ghia